Healthcare ❯ Pharmaceuticals

Pain Management

Paracetamol Oxycontin Safety Guidelines Pain Portfolio Jornay PM Non-Opioid Painkillers Alternative Pain Relief Medications Chronic Conditions Non-Opioid Therapies ADHD Treatment Chronic Pain

Collegium Reports Record 2025 Results, Projects Strong 2026 for Jornay as Hikma Generic Nears

A stronger cash position with low leverage gives the company flexibility.

Semnur Goes Public via Denali SPAC, Unveils $100 Million Bitcoin Stock Sale Plan

Frequent Gabapentin Prescriptions Tied to Increased Dementia and Cognitive Impairment Risk